Call for Papers: Brain-lung crosstalk
Published in Healthcare & Nursing and General & Internal Medicine
Brain-injured patients are more likely to develop respiratory disorders and vice versa because the brain and the lungs communicate through complex bi-directional pathways which are not yet fully understood. There is a need for increased knowledge of the neuroanatomical, humoral, immune and metabolic pathways that the brain and lung use to talk to each other. Therefore, BMC Pulmonary Medicine has launched a call for papers to bring together research on the mechanisms underlying crosstalk between the brain and the lungs as well as studies investigating the epidemiology, pathophysiology and management of lung disorders in brain-injured patients to create an open access resource for all those interested in the field.
To learn more about the Collection’s scope, read the opening editorial written by the Guest Editors, which discusses recent advances, knowledge gaps and challenges faced by researchers investigating crosstalk between the brain and the lungs.
Meet the Guest Editors
Denise Battaglini: Consultant in Neuro and General Intensive Care, Policlinico San Martino Hospital, Italy
Denise Battaglini is Consultant in Intensive Care at San Martino Policlinico Hospital, Genoa, Italy. Dr Battaglini is attending a PhD in Translational Medicine at the University of Barcelona, Spain. She attended two research fellowhips in pneumonia and respiratory physiotherapy at the University of Barcelona, Spain, and in neurological and pulmonary critical care at the Federal University of Rio de Janeiro, Brazil. She is involved in several research projects regarding critical care management of patients with pulmonary and neurological diseases, neurological complications of COVID-19 ARDS, ventilator-associated pneumonia, respiratory physiotherapy, and lung-and-gut microbiota in neurocritically ill patients.
Chiara Robba: Consultant in Neuro and General Intensive Care, Policlinico San Martino Hospital, Italy
James A. Town: Assistant Professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Director, Medical Intensive Care Unit, Harborview Medical Center, University of Washington, Seattle, Washington.
Dr Town is an Assistant Professor of Pulmonary and Critical Care Medicine at the University of Washington. He works in the Intensive Care Units at Harborview Medical Center where he is also the Director of the Medical ICU. His clinical and academic interests are in quality improvement, post-cardiac arrest care, bedside ultrasound and medical education.
Sarah Wahlster: Section Head, Neurocritical Care in the Department of Neurology at the University of Washington, Seattle, Washington
Dr Wahlster obtained her medical degree at the Ruprecht-Karls Universität Heidelberg, followed by a post-doc in Epigenetics of Neurodegenerative Disease at Harvard Medical School. She completed neurology residency and neurocritical care fellowship at MassGeneral/Brigham in Boston, and is now the section head of Neurocritical Care in the Department of Neurology at Harborview Medical Center. Her academic interests include Mechanical Ventilation in Acute Brain Injury, Extubation and Tracheostomy Decisions in the NeuroICU, Long-Term Outcomes of Patients and their Families After Severe Acute Brain Injury, Neuroprognostication after Cardiac Arrest, Neurological Care in Resource-Limited Settings, and Medical Education.
Submission Guidelines
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select “Brain-lung crosstalk” from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Submission Status: Open | Submission Deadline: 10 January 2024
Follow the Topic
-
BMC Pulmonary Medicine
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With collections, you can get published faster and increase your visibility.
Artificial intelligence and machine learning: applications in pulmonary medicine
BMC Pulmonary Medicine is calling for submissions to our Collection on Artificial intelligence and machine learning: applications in pulmonary medicine. Advancements in artificial intelligence (AI) and machine learning (ML) have the potential to revolutionize pulmonary medicine by enabling innovative approaches to diagnosis, treatment, and prevention of pulmonary disorders. In this era of rapid technological advancements, AI can assist in early detection, risk assessment, and prognostic evaluation by analyzing large datasets, thus leading to improved patient outcomes and better management strategies.
BMC Pulmonary Medicine is launching this collection in alignment with the United Nations' Sustainable Development Goals (SDGs) 3: Good health and well-being and SDG 10: Reduced inequalities. The aim of this collection is to consolidate both fundamental and clinical research to advance our comprehension of pulmonary disorders.
BMC Pulmonary Medicine welcomes original research on the design, implementation, optimization, and clinical impact of AI applications in the field of pulmonary medicine. Topics of interest include, but are not limited to, the following:
• Machine learning (ML) algorithms for early detection of pulmonary diseases
• AI applications for diagnostic accuracy studies
• AI systems as an intervention in live clinical settings
• Predictive modeling using AI for personalized risk assessment of pulmonary disorders
• Application of AI in pulmonary imaging analysis
• Utilizing natural language processing and AI for analyzing electronic health records in pulmonary care
• Exploring the potential of AI in optimizing pulmonary surgical procedures
• Wearable devices and AI algorithms for continuous monitoring of pulmonary health
• AI-enabled precision medicine approaches for personalized treatment
• AI-powered automated risk scoring systems for exacerbations of pulmonary diseases
• Ethical considerations and challenges in the implementation of AI in pulmonary medicine
We encourage the use of standardized reporting guidelines for research with AI/ ML components to encourage authors to provide information to allow their work to be evaluated appropriately. Reporting guidelines and checklists have been developed for a broad range of study design and research types with AI/ML components.
Publishing Model: Open Access
Deadline: Jul 29, 2025
Remote monitoring of chronic lung disease
BMC Pulmonary Medicine calls for submissions to our Collection on Remote monitoring of chronic lung disease. Chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, occupational lung diseases and pulmonary hypertension pose significant challenges for patients and healthcare systems. Remote monitoring, facilitated by telehealth, telemedicine, wearable technology, and digital health solutions, has emerged as a promising approach to improve the management of chronic lung diseases. This Collection aims to gather research that explores the use of remote monitoring technologies in the home-based management of chronic lung diseases, including their impact on patient outcomes, healthcare utilization, and quality of life.
Advancing our collective understanding in this area is crucial for optimizing the use of remote monitoring technologies in chronic lung disease management. Recent advances have demonstrated the potential of remote monitoring to enhance disease management, facilitate early intervention, and improve patient self-management skills. Furthermore, research has highlighted the role of telehealth in promoting patient engagement and adherence to treatment plans, ultimately leading to better health outcomes.
Looking ahead, continued research in this area holds the potential for further advancements in remote monitoring technologies, including the integration of artificial intelligence for real-time data analysis, personalized treatment recommendations, and predictive modeling for exacerbation risk. Additionally, ongoing research efforts may lead to the development of innovative telehealth interventions that address the specific needs of patients with chronic lung diseases, ultimately improving their long-term health outcomes.
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being, addressing a broad spectrum of topics, including but not limited to:
• Remote monitoring for chronic lung disease management
• Telehealth interventions for chronic lung disease care
• Wearable technology in chronic lung disease management
• Digital health solutions for home-based monitoring of chronic lung diseases
Publishing Model: Open Access
Deadline: Aug 22, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in